A diagnostic company needed a single ultra-high throughput expression analysis process – lysis through to final library QC, that could be used with multiple, challenging, differentiated cells lines.
We built out a derivative of Drug-Seq allowing early stage pooling of 384 samples, including optimization of lysis conditions and worked with their automation team to implement the methods on their robots.